Lapatinib | compare suppliers & send inquiries for free
Looking for Lapatinib 231277-92-2?
You can find a short description about Lapatinib here. Lapatinib is an anti-cancer drug developed by GSK (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Lapatinib manufacturers | traders | suppliers
We have 8 companies offering Lapatinib from 4 different countries.
Get in contact with the supplier of your choice:
- JINLAN Pharm-Drugs Technology Co., Ltd. from China
- Suzhou Bichal Biological Technology from China
- Hetero Labs from India
- Scinopharm from Taiwan
- Adley Formulations from India
- ALP PHARM from China
- Formosa Labs from Taiwan
- Cambrex Charles City from United States
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.